KS

Kalagoni Srinivas

Active Director Director DIN 08575021
DIN 08575021 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Kalagoni Srinivas

Data last updated:

Kalagoni Srinivas is a Director at Docheal Pharma Private Limited (since 2021). The company operates in Pharma. Docheal Pharma Private Limited reported revenue of ₹34.4 Lakh (FY 2022).

DIN 08575021
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2021
Oldest Company Age 8 yrs
Largest company Docheal Pharma Private Limited · ₹34.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Docheal Pharma Private Limited U74999TG2018PTC126887
Director11 Jan 20212018₹34.4 Lakh (FY 2022)Active

Board colleagues of Kalagoni Srinivas

Directorship timeline

Open interactive timeline →
Docheal Pharma Private Limited
Premium access

Shareholding and investment profile for Kalagoni Srinivas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalagoni Srinivas

Kalagoni Srinivas currently holds 1 directorship: Docheal Pharma Private Limited (Director, since 11 Jan 2021, revenue ₹34.4 Lakh (FY 2022)).

Kalagoni Srinivas was first appointed on 11 Jan 2021 as Director at Docheal Pharma Private Limited.

The current boards of Kalagoni Srinivas's companies include Lalitha Chityala (Docheal Pharma Private Limited), Viswanath Mallela (Docheal Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available